title: Substituting nevirapine for protease inhibitors because of intolerance.
authors.forename: J P
authors.initials: JP
authors.lastname: Dieleman
authors.forename: I C
authors.initials: IC
authors.lastname: Gyssens
authors.forename: M J
authors.initials: MJ
authors.lastname: Sturkenboom
authors.forename: H G
authors.initials: HG
authors.lastname: Niesters
authors.forename: M E
authors.initials: ME
authors.lastname: van der Ende
mesh_terms: D000328:Adult; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D017320:HIV Protease Inhibitors / Q000009:adverse effects*; D015497:HIV-1 / Q000187:drug effects / Q000502:physiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D019829:Nevirapine / Q000627:therapeutic use*; D012367:RNA, Viral / Q000097:blood; D012189:Retrospective Studies; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D019562:Viral Load
chemical_list: D017320:HIV Protease Inhibitors; D012367:RNA, Viral; D018894:Reverse Transcriptase Inhibitors; D019829:Nevirapine